Related Experiment Video
Updated: Aug 30, 2025

Identification of Circular RNAs using RNA Sequencing
Published on: November 14, 2019
An Overview of the Advances in Research on the Molecular Function and Specific Role of Circular RNA in Cardiovascular
Lianli Yin1, Yinghua Tang2, Yulin Yuan1
1Department of Clinical Laboratory, Guangxi Academy of Medical Sciences, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, 530021 Guangxi, China.
Insights
Circular RNAs (circRNAs) are emerging as key players in cardiovascular disease (CVD). Dysregulated circRNA expression is linked to CVD development and complications, offering new diagnostic and therapeutic avenues.
Area of Science:
- Molecular Biology
- Genetics
- Cardiovascular Medicine
Background:
- Cardiovascular disease (CVD) remains a leading cause of mortality globally, with China reporting the highest death rates.
- Circular RNAs (circRNAs), structurally stable closed-loop transcripts, are increasingly recognized for their regulatory roles in eukaryotes.
- Emerging evidence links aberrant circRNA expression to metabolic diseases, including hypertension and CVD.
Purpose of the Study:
- To review the current understanding of circRNAs in the context of cardiovascular disease.
- To elucidate the role of circRNAs as potential biomarkers for CVD and related conditions.
- To propose novel research strategies for analyzing circRNAs in cardiovascular medicine.
Main Methods:
- Literature review of studies on circRNA expression and function in cardiovascular disease.
- Analysis of existing research on circRNAs as microRNA sponges and RNA-binding proteins.
- Synthesis of findings linking circRNA dysregulation to CVD pathogenesis and complications.
Main Results:
- CircRNAs exhibit distinct tissue specificity and are widely distributed in eukaryotes.
- Dysregulated circRNA expression is an early indicator in metabolic diseases like hypertension and CVD.
- CircRNAs contribute to cardiovascular complications and serve as potential biomarkers.
Conclusions:
- CircRNAs represent a significant area of research for understanding CVD mechanisms.
- Innovative biomarkers based on circRNAs can aid in the diagnosis and management of cardiovascular events.
- Further analysis of circRNAs offers new strategies for medical research in cardiovascular disease.
Abstract:
In recent years, the rate of residents suffering from cardiovascular disease (CVD), disability, and death has risen significantly. The latest report on CVD in China shows that it still has the highest mortality rate of all diseases in that country. Different from linear RNA, circular RNA (circRNA) is a covalently closed transcript, mainly through reverse splicing so that the 3'end and the 5'end are covalently connected to form a closed loop structure. It is structurally stable and abundant and has distinct tissue or cell specificity, and it is widely distributed in eukaryotes. Although circRNAs were discovered many years ago, researchers have only recently begun to slowly discover their extensive expression and regulatory functions in various biological processes. Studies have found that some circRNAs perform multiple functions in cells more used as RNA binding protein or microRNA sponge. In addition, accumulating evidence shows that the first change that occurs in patients with various metabolic diseases such as hypertension and cardiovascular disease is dysregulated circRNA expression. For cardiovascular and other related blood vessels, circRNA is one of the important causes of various complications. These findings contribute to a more comprehensive understanding and grasp of CVD, and the related molecular mechanisms of CVD should be further analyzed. Here, we review the new understanding of circRNAs in CVD and explain the role of these innovative biomarkers in the analysis and determination of other related cardiovascular events such as coronary heart disease. Thus, this study is aimed at providing new ideas and proposing more feasible medical research strategies based on circRNA.
Related Concept Videos
Coronary Artery Disease I: Introduction
Regulation of the Cardiovascular System
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Experimental RNAi
Coronary Artery Disease II: Pathophysiology
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

